These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29138858)

  • 1. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
    Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
    Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
    Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
    Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.
    Dai Y; Ren D; Yang Q; Cui Y; Guo W; Lai Y; Du H; Lin C; Li J; Song L; Peng X
    Br J Cancer; 2017 Aug; 117(5):685-694. PubMed ID: 28697177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.
    Huang S; Wa Q; Pan J; Peng X; Ren D; Li Q; Dai Y; Yang Q; Huang Y; Zhang X; Zhou W; Yuan D; Cao J; Li Y; He P; Tang Y
    Cell Death Dis; 2018 Jul; 9(7):779. PubMed ID: 30006541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.
    Feng S; Zhu X; Fan B; Xie D; Li T; Zhang X
    Mol Med Rep; 2016 May; 13(5):4030-8. PubMed ID: 27035427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
    Sun B; Fan Y; Yang A; Liang L; Cao J
    J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
    Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
    Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
    Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
    Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.
    Siu MK; Tsai YC; Chang YS; Yin JJ; Suau F; Chen WY; Liu YN
    Oncogene; 2015 Sep; 34(36):4767-76. PubMed ID: 25531317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
    Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
    Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
    Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
    Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ Induces a Pro-Bone Metastasis Program in Prostate Cancer.
    Cancer Discov; 2015 Jul; 5(7):OF23. PubMed ID: 26022606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI.
    Zhu M; Chen Q; Liu X; Sun Q; Zhao X; Deng R; Wang Y; Huang J; Xu M; Yan J; Yu J
    FEBS J; 2014 Aug; 281(16):3766-75. PubMed ID: 24988946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis.
    Zhu Z; Wen Y; Xuan C; Chen Q; Xiang Q; Wang J; Liu Y; Luo L; Zhao S; Deng Y; Zhao Z
    FEBS Open Bio; 2020 Apr; 10(4):674-688. PubMed ID: 32027093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
    Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
    Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.